Evidence map›Paper›PMID 35307873›Full record

ArticleImmunology and cell biology2022

CD4

Amanda Xy Chen, Emily B Derrick, Paul A Beavis, Imran G House

Abstract readComment
PubMed Publisher
In one paragraph

Article in Immunology and cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Amanda Xy ChenCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0002-1388-9510
Emily B DerrickCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0001-7191-3948
Paul A BeavisCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0002-2116-013X
Imran G HouseCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0002-6245-5954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a recently published article, Melenhorst et al. performed a longitudinal analysis on chimeric antigen receptor (CAR) T cells isolated from patients over 10 years after therapy, revealing expansion of a long-lived CD4

Indexed as

Receptors, Chimeric AntigenCD4-Positive T-LymphocytesHumansImmunotherapy, AdoptiveReceptors, Antigen, T-CellT-LymphocytesReceptors, Antigen, T-CellReceptors, Chimeric Antigenchimeric antigen receptor T cellscytotolytic CD4+ T cellspersistence

Identifiers

PMID35307873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.